Medicare Enrolled

Dr. Roy Lehman, MD

Ophthalmology · Sherman, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
1625 N US HIGHWAY 75, Sherman, TX 75090
9038923282
In practice since 2011 (14 years)
NPI: 1124314067 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lehman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lehman

Dr. Roy Lehman is an ophthalmology in Sherman, TX, with 14 years in practice. Based on federal Medicare data, Dr. Lehman performed 7,788 Medicare services across 2,373 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lehman received a total of $9,434 from 30 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lehman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 12% volume in TX$ $9,434 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,788
Medicare services
Top 12% in TX for ophthalmology
2,373
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~556 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)4,140$29$187
Corneal topography and eye depth measurement696$18$87
Cataract surgery with lens implant379$351$1,435
Eye exam, established patient, focused333$62$165
Retinal imaging (OCT scan)262$28$88
Eye injection for retinal disease238$79$250
Aflibercept eye injection (Eylea)234$689$1,961
Removal of recurring cataract in lens capsule using a laser218$216$700
New patient office visit (45-59 min)209$106$314
Comprehensive eye exam, established patient144$82$237
Office visit, established patient (20-29 min)134$57$139
Comprehensive eye exam, new patient95$100$287
Office visit, established patient (30-39 min)77$85$200
Optic nerve imaging (OCT scan)67$25$86
Photography of content of eyes67$15$55
Visual field test, extended65$43$125
Closure of tear duct opening using plug59$148$541
Compounded drug, not otherwise classified44$62$200
New patient problem focused exam of visual system40$58$157
Removal of excessive skin and fat of upper eyelid36$602$5,000
Dilation of fluid outflow drainage within eye30$227$1,880
Removal of growth of cornea29$423$1,325
Placement of amniotic membrane on eye surface for wound healing29$964$2,687
Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye26$450$2,000
Ct scan of cornea23$25$73
Exam of visual field with intermediate testing23$34$100
New patient office visit (30-44 min)23$71$205
Complex removal of cataract with insertion of prosthetic lens19$491$1,565
Retinal photography (fundus photo)18$26$166
Ultrasound scan of cornea to determine thickness16$7$30
Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis15$462$1,956
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
63.9% medium
31.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,434
Total received (2018-2024)
Avg $1,348/year across 7 years
Top 13% in TX for ophthalmology
30
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,680 (60.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,733 (39.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$490
2023
$4,520
2022
$346
2021
$542
2020
$2,354
2019
$1,000
2018
$182

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
RxSight Inc
$4,236
Ivantis, Inc
$1,535
Alcon Vision LLC
$446
Glaukos Corporation
$413
Allergan, Inc.
$339
ABBVIE INC.
$307
Bausch & Lomb Americas Inc.
$264
Bausch & Lomb, a division of Bausch Health US, LLC
$259
BIOTISSUE HOLDINGS INC.
$224
EllexiScience
$221
Novartis Pharmaceuticals Corporation
$219
Alcon Laboratories Inc
$150
Johnson & Johnson Surgical Vision, Inc.
$147
Bausch Health US, LLC
$102
Sight Sciences, Inc.
$98
Ocular Therapeutix, Inc.
$98
LENSAR, Inc.
$74
TISSUETECH, INC.
$45
Regeneron Healthcare Solutions, Inc.
$39
Allergan Inc.
$32
Genentech USA, Inc.
$26
BIOTISSUE HOLDINGS, INC.
$25
Biogen, Inc.
$20
Carl Zeiss Meditec, Inc.
$20
Dompe US, Inc.
$18
Shire North American Group Inc
$18
Harrow Eye, LLC
$16
Beaver-Visitec International, Inc.
$15
Carl Zeiss Meditec USA, Inc.
$15
Aerie Pharmaceuticals, Inc.
$14
Top 3 companies account for 65.9% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · AcrySof · AcrySof IQ PanOptix · Argos 1.5 biometer · BEOVU · Catalys Laser System · DEXTENZA · DURYSTA · ENVISTA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Hydrus · ILUX · IOLMaster 500 · KXL System · LENSAR LASER SYSTEM · LenSx · Lucentis · Luxor · MIEBO · NGENUITY · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · Oxervate · PROKERA · PROLENSA · PanOptix · RESTASIS · RXSIGHT CONTACT LENS · ReSTOR · SMART Suite · STELLARIS · TORIC · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Symfony IOL · VEVYE · VICTUS · VYZULTA · Whitestar Phacoemulsficiation System · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · enVista MX60 IOL · iDose · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $121 per 100 Medicare services performed
Looking for a ophthalmology in Sherman?
Compare ophthalmologys in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
8
Per 100K population
5.7
County median income
$70,455
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL AT SHERMA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lehman is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (consulting-driven, top 13%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lehman experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lehman performed 4,140 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lehman receive payments from pharmaceutical companies?
Yes. Dr. Lehman received a total of $9,434 from 30 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lehman's costs compare to other ophthalmologys in Sherman?
Dr. Lehman's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →